• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

RHEUM for Discussion: Ultrasound in Early Diagnosis, and Debating Hot Topics in RA


This interactive symposium will begin with a talk on the pivotal role of identifying early indicators in RA, leveraging ultrasound and cutting-edge technologies such as AI for early detection. It will also explore gaps that impede timely diagnosis and strategies to foster the involvement of a multidisciplinary team.

The faculty will look at how real-world evidence (RWE) can complement clinical trials, and how the assessment of benefits and risks of each option can guide treatment decisions. They will dissect existing treatments’ safety, efficacy and patient-reported outcomes through a dynamic debate and discussion session on various topics, including the intricate selection of treatments, guidelines-based treat-to-target approaches, the pursuit of patient-centric care, as well as screening and managing comorbidities.

Learning objectives:

  1. Understand the importance of early diagnosis and the role of imaging tools, such as ultrasound and artificial intelligence (AI), in identifying patients with RA for timely treatment
  2. Develop optimized management strategies based on updated clinical trial data and real-world evidence to balance treatment benefits and risks for individual patients
  3. Implement patient-centered care through shared decision-making in clinical practice
Welcome & introduction

Prof Worawit Louthrenoo
The role of ultrasound and AI in the early diagnosis and treatment of RA

Prof Annamaria Iagnocco
Let’s agree to disagree: Debating the “what to choose” and “when to use” in RA management.
Should JAK inhibitors or TNF inhibitors be used after methotrexate failure in RA?

Dr Masato Okada
Dr Maureen Rischmueller
Summary and closing remarks

Prof Worawit Louthrenoo

9th December, 1315-1435 (Thailand Local Time)

Chiang Mai International Exhibition and Convention Centre, Convention Hall 1

Share This Post

Translate »